LEADER 03587oam  2200793I  450 
001 9910782967103321
005 20230421041917.0
010   $a0-429-17889-1
010   $a1-4822-7253-9
010   $a9786610195640
010   $a1-280-19564-9
010   $a0-585-46045-0
010   $a0-203-21151-0
024 7 $a10.1201/9781482272536
035   $a(CKB)1000000000003542
035   $a(EBL)165671
035   $a(OCoLC)70755753
035   $a(SSID)ssj0000298162
035   $a(PQKBManifestationID)11254019
035   $a(PQKBTitleCode)TC0000298162
035   $a(PQKBWorkID)10343911
035   $a(PQKB)11062159
035   $a(SSID)ssj0000167431
035   $a(PQKBManifestationID)11155566
035   $a(PQKBTitleCode)TC0000167431
035   $a(PQKBWorkID)10178898
035   $a(PQKB)23895614
035   $aebr2003598
035   $a(MiAaPQ)EBC165671
035   $a(Au-PeEL)EBL165671
035   $a(CaPaEBR)ebr10070472
035   $a(CaONFJC)MIL19564
035   $a(OCoLC)1000432543
035   $a(EXLCZ)991000000000003542
100   $a20180706d1995      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aHandbook of drugs for tropical parasitic infections /$fYakoub Aden Abdi. [et al.]
205   $a2nd ed.
210  1$aLondon ;$aBristol, Pa. :$cTaylor & Francis,$d1995.
215   $a1 online resource (192 p.)
300   $aPrevious ed. cataloged under author Gustafsson.
311   $a0-7484-0167-9 
311   $a0-7484-0168-7 
320   $aIncludes bibliographical references and index.
327   $aBook Cover; Title; Contents; Preface; Acknowledgement; Abbreviations; Introduction; Drug recommendations; Albendazole; Amphotericin B; Antimony compounds; Artemisinin and derivatives; Bephenium hydroxynaphthoate; Bithionol; Chloroquine; Dehydroemetine; Diethylcarbamazine; Diloxanide; Eflornithine; Halofantrine; Ivermectin; Levamisole; Mebendazole; Mefloquine; Melarsoprol; Metrifonate; Metronidazole; Niclosamide; Nifurtimox; Oxamniquine; Pentamidine; Piperazine; Praziquantel; Primaquine; Proguanil; Pyrantel; Pyrimethamine; Pyrvinium pamoate; Quinine; Sulphadoxine; Suramin; Tetracyclines
327   $aThiabendazoleTinidazole; Index
330   $aParasitic infections such as malaria, schistosomiasis, trypanosomiasis and onchoceriasis are the scourge of the tropical countries. Many of the drugs used for the treatment of tropical parasitic infections were introduced more than 30 years ago. Most of these drugs are toxic and have complicated dosage regimens, but, because of the low economic incentive, pharmaceutical companies have shown little interest in developing new drugs to control diseases prevalent in developing countries.; However, there has been notable progress in research into parasitic diseases and a number of important drugs h
606   $aAntiparasitic agents$vHandbooks, manuals, etc
606   $aAntiprotozoal Agents$xtherapeutic use
606   $aParasitic Diseases$xdrug therapy
606   $aTropical Medicine
608   $aHandbook.
615  0$aAntiparasitic agents
615 12$aAntiprotozoal Agents$xtherapeutic use.
615 22$aParasitic Diseases$xdrug therapy.
615 22$aTropical Medicine.
676   $a616.9/6061
701   $aAbdi$b Y. A$g(Yakoub Aden)$01497992
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910782967103321
996   $aHandbook of drugs for tropical parasitic infections$93723345
997   $aUNINA